Paul Koller, M.D.
Duarte - Main Campus
Duarte, CA 91010
2018 American Board of Internal Medicine- Hematology
2018 American Board of Internal Medicine- Medical Oncology
2015 American Board of Internal Medicine- Internal Medicine
2012, M.D., Medicine, University of Texas, Houston, TX
2015-2018, Hematology/Oncology Fellow, Supervisor: Robert Wolff, M.D., Department of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX
2012-2015, Internal Medicine, Supervisor: Richard Hamill, M.D., Department of Internal Medicine, Baylor College of Medicine Affiliated Hospitals, Houston, TX
2019-present, Assistant Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California
2018-2019, Instructor, Department of Leukemia, MD Anderson Cancer Center, Houston, TX
2018, Conquer Cancer Foundation of ASCO/Texas Society of Clinical Oncology Young Investigator Award
2018, Top recipients of the 2018 TxSCO Fellows Research Competition
-
Amanam I, Yao J, Puing A, Tsai NC, Samuels D, Ngo D, Ho S, Ali H, Aribi A, Arslan S, Artz A, Htut M, Koller P, Salhotra A, Sandhu K, Nikolaenko L, Pawlowska A, Shouse G, Stein A, Marcucci G, Forman S, Nakamura R, Dadwal S, Al Malki MM. Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience. Cancer Med. 2023 May;12(10):11248-11253. doi: 10.1002/cam4.5832. Epub 2023 Apr 20. PMID: 37081733; PMCID: PMC10242327.
-
Agrawal V, Pourhassan H, Tsai NC, Ngo D, Koller P, Malki MMA, Salhotra A, Ali H, Aribi A, Sandhu KS, Arslan S, Ball B, Otoukesh S, Amanam I, Artz A, Singh D, Becker PS, Stewart FM, Smith EP, Curtin P, Stein AS, Marcucci G, Forman SJ, Nakamura R, Pullarkat V, Aldoss I. Post-Transplantation Sinusoidal obstruction syndrome in adult patients with B cell acute lymphoblastic leukemia treated with pretransplantation Inotuzumab. Transplant Cell Ther. 2023 May;29(5):314-320. doi: 10.1016/j.jtct.2023.01.017. Epub 2023 Jan 19.PMID:36682470
-
Tinajero J, Koller P, Ali H. Ponatinib, Asciminib and inotuzumab ozogamicin: A novel drug combination in acute lymphoblastic leukemia. Leuk Res. 2023 Apr 23;129:107299. doi: 10.1016/j.leukres.2023.107299. Online ahead of print.PMID:37120933
-
Garcia JS, Flamand Y, Penter L, Keng M, Tomlinson BK, Mendez LM, Koller P, Cullen N, Arihara Y, Pfaff K, Wolff JO, Brunner AM, Galinsky I, Bashey A, Antin JH, Cutler C, Ho V, Jonas BA, Luskin MR, Wadleigh M, Winer ES, Savell A, Leonard R, Robertson T, Davids MS, Streicher H, Rodig SJ, Ritz J, Wu CJ, DeAngelo DJ, Neuberg D, Stone RM, Soiffer RJ. Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings. Blood. 2023 Apr 13;141(15):1884-1888. doi: 10.1182/blood.2022017686.PMID:36332187
-
Amanam I, Yao J, Puing A, Tsai NC, Samuels D, Ngo D, Ho S, Ali H, Aribi A, Arslan S, Artz A, Htut M, Koller P, Salhotra A, Sandhu K, Nikolaenko L, Pawlowska A, Shouse G, Stein A, Marcucci G, Forman S, Nakamura R, Dadwal S, Al Malki MM. Use of monoclonal antibody therapy in hematologic patients with mild-to-moderage COVID-19: A retrospective since center experience. Cancer Med. 2023 Apr 20. doi: 10.1002/cam4.5832. Online ahead of print.PMID:37081733
-
Aldoss I, Afkhami M, Yang D, Gu Z, Mokhtari S, Shahani S, Pourhassan H, Agrawal V, Koller P, Arslan S, Tomasian V, Al Malki MM, Artz A, Salhotra A, Ali H, Aribi A, Sandhu KS, Ball B, Otoukesh S, Amanam I, Becker PS, Stewart FM, Curtin P, Smith E, Telatar M, Stein AS, Marcucci G, Forman SJ, Nakamura R, Pullarkat V. High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions. Am J Hematol. 2023 Mar 7. doi: 10.1002/ajh.26908. Online ahead of print.PMID:36880203
-
Ball, BJ*, Arslan, S*, Koller, P*,et al. Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged Acute Myeloid Leukemia (AML). Leuk Lymphoma. 2022 Dec;63(13):3232-3236. doi: 10.1080/10428194.2022.2116934. Epub 2022 Sep 10.PMID:36089918
-
Ball BJ, Koller PB, Pullarkat, V. Venetoclax in combination with nucleoside analogs in acute myelogenous leukemia. Curr Opin Oncol. 2022 Sep 1;34(5):531-539. doi: 10.1097/CCO.0000000000000868. Epub 2022 Jul 16.PMID:35855507
-
Ngo D, Samuels D, Chen J, Koller PB, Al Malki MM. A Clinical Review of the Different strategies to minimize Hemorrhagic Cystitis associated with the use of Post-transplantation Cyclophosphamide in an Allogeneic Transplant. Transplant Cell Ther. 2022 Jul;28(7):349-354. doi: 10.1016/j.jtct.2022.05.012. Epub 2022 May 14.PMID:35580733
-
Aldoss I, Yang D, Tomasian V, Mokhtari S, Jackson R, Gu Z, Telatar M, Yew H, Al Malki MM, Salhotra A, Khaled S, Ali H, Aribi A, Sandhu KS, Mei MG, Arslan S, Koller PB, Artz AS, Aoun P, Gu D, Snyder DS, Stewart F, Curtin PT, Stein AS, Pillai RK, Marcucci G, Forman SJ, Pullarkat VA, Nakamura R, Afkhami M. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Adults with Fusions Associated with Ph-like ALL. Blood Adv. 2022 Sep 13;6(17):4936-4948. doi: 10.1182/bloodadvances.2022007597.PMID:35816633